306 studies found for:    Open Studies | "Pelvis"
Show Display Options
Rank Status Study
21 Recruiting A Comparative Effectiveness Study Between Two Methods of Reconstruction of Pelvic Floor After Rectal Excision in Advanced Rectal Cancer
Conditions: Rectal Cancer;   Defect of Floor of Lesser Pelvis
Interventions: Procedure: Reconstruction of floor of lesser pelvis with an acellular porcine collagen implant;   Procedure: Reconstruction of floor of lesser pelvis with a gluteus maximus flap
22 Recruiting Efficacy of Gralise® for Chronic Pelvic Pain
Conditions: Irritable Bowel Syndrome;   Ulcerative Colitis;   Interstitial Cystitis;   Prostatitis;   Pelvic Pain
Intervention: Drug: Gralise
23 Recruiting Study of Ramucirumab or IMC-18F1 With Docetaxel or Docetaxel Alone as Second-Line Therapy in Participants With Bladder,Urethra, Ureter, or Renal Pelvis Carcinoma
Conditions: Carcinoma of Urinary Tract;   Urethral Carcinoma;   Carcinoma of Ureter;   Carcinoma of Renal Pelvis
Interventions: Drug: Docetaxel;   Biological: Ramucirumab DP;   Biological: IMC-18F1
24 Recruiting The Impact of Oral Contrast in Multidetector CT of the Abdomen and Pelvis on Radiologist Confidence
Condition: Routine Outpatients Undergoing Contrast Enhanced CT Scan of the Abdomen and Pelvis
Intervention: Other: Withhold oral contrast
25 Unknown  Female Chronic Pelvic Pain
Conditions: Pelvic Pain;   Abdominal Pain;   Painful Bladder Syndrome;   Interstitial Cystitis;   Irritable Bowel Syndrome
Intervention: Other: Chronic pelvic pain
26 Recruiting The Optimal Oblique and Axial Angle of Fluoroscope for Superior Hypogastric Plexus Block
Conditions: Chronic Pelvic Pain;   Pelvic Malignancy;   Superior Hypogastric Plexus Block
Intervention:
27 Recruiting Surgical Success After Laparoscopic vs Abdominal Hysterectomy
Conditions: Metrorrhagia;   Menorrhagia;   Leiomyoma;   Adenomyosis;   Pelvic Pain;   Endometriosis;   Pelvic Inflammatory Disease
Interventions: Procedure: Laparoscopic hysterectomy;   Procedure: Abdominal hysterectomy
28 Unknown  Surgical Correction of Pelvic Organ Prolapse
Condition: Pelvic Organ Prolapse
Intervention: Procedure: Colposacropexy
29 Unknown  Medical Treatment of Endometriosis-Associated Pelvic Pain
Conditions: Endometriosis;   Pelvic Pain
Interventions: Drug: Oral Contraceptive;   Drug: Depot-Leuprolide/Norethindrone
30 Unknown  Bowel Preparation and Pelvic Organ Prolapse Surgery
Condition: Pelvic Organ Prolapse
Intervention: Other: Bowel preparation (Fleets enema)
31 Recruiting Soft Tissue Graft for Repair of Pelvic Organ Prolapse
Condition: Pelvic Organ Prolapse
Intervention: Device: Surgisis® Soft Tissue Graft
32 Not yet recruiting Timing of Pessary Follow-up for Pelvic Organ Prolapse
Conditions: Pelvic Organ Prolapse;   Pessary
Intervention: Other: 12 week follow up for pessary check in the clinic setting
33 Recruiting Ischia Spinous Fascia Fixation Surgery for Pelvic Organ Prolapse
Condition: Pelvic Organ Prolapse
Intervention: Procedure: ISFF
34 Recruiting Evaluating the Necessity of TOT Implantation in Women With Pelvic Organ Prolapse and Occult Stress Urinary Incontinence
Conditions: Stress Urinary Incontinence;   Pelvic Organ Prolapse
Interventions: Procedure: Pelvic Organ Prolapse and Suburethral TOT implantation;   Procedure: Pelvic Organ Prolapse intervention
35 Recruiting Systemic Markers of Collagen Metabolism and Vitamin C in Smokers and Non-Smokers With Pelvic Organ Prolapse
Condition: Pelvic Organ Prolapse
Intervention: Other: Blood draw for the study participants
36 Recruiting Chemokine Mechanisms in Chronic Pelvic Pain
Conditions: Chronic Prostatitis/Chronic Pelvic Pain Syndrome;   Prostatitis
Intervention:
37 Recruiting Rating Pelvic Organs Prolapse in Women According to the POPQ Method Before and After Emptying the Urinary Bladder
Condition: Patients With Pelvic Organs Prolapse
Intervention: Device: Medtronic-Dantec Urodynamic System
38 Unknown  Botulinum Toxin Type A for the Treatment of Male Chronic Pelvic Pain Syndrome
Conditions: Chronic Prostatitis With Chronic Pelvic Pain Syndrome;   Prostatitis
Interventions: Drug: Botulinum Toxin Type A;   Drug: Placebo
39 Recruiting Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
Conditions: Distal Urethral Cancer;   Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter;   Proximal Urethral Cancer;   Recurrent Bladder Cancer;   Recurrent Prostate Cancer;   Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter;   Recurrent Urethral Cancer;   Stage IV Bladder Cancer;   Stage IV Prostate Cancer;   Transitional Cell Carcinoma of the Bladder;   Urethral Cancer Associated With Invasive Bladder Cancer
Interventions: Drug: gemcitabine hydrochloride;   Drug: cisplatin;   Other: placebo;   Biological: bevacizumab;   Other: laboratory biomarker analysis
40 Recruiting Veliparib, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Advanced Biliary, Pancreatic, Urothelial, or Non-Small Cell Lung Cancer
Conditions: Advanced Adult Primary Liver Cancer;   Localized Unresectable Adult Primary Liver Cancer;   Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter;   Regional Transitional Cell Cancer of the Renal Pelvis and Ureter;   Stage III Bladder Cancer;   Stage III Pancreatic Cancer;   Stage IIIA Non-small Cell Lung Cancer;   Stage IIIB Non-small Cell Lung Cancer;   Stage IV Bladder Cancer;   Stage IV Non-small Cell Lung Cancer;   Stage IV Pancreatic Cancer;   Transitional Cell Carcinoma of the Bladder;   Unresectable Extrahepatic Bile Duct Cancer;   Unresectable Gallbladder Cancer
Interventions: Drug: gemcitabine hydrochloride;   Drug: veliparib;   Other: diagnostic laboratory biomarker analysis;   Other: pharmacological study;   Drug: cisplatin

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years